After serving as the chief executive officer of a major multi-national organisation, Mazi Sam Ohuabunwa went on to form one of Nigeria’s leading pharmaceutical entities, Neimeth International, through a buy-out deal from the same company, Pfizer International, where he started his career and rose
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
BusinessDay
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
